Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy

Head Neck. 2008 Dec;30(12):1543-51. doi: 10.1002/hed.20901.

Abstract

Background: Treatment of head and neck mucosal melanoma remains a challenge. Surgery has traditionally been the main therapeutic approach. The role of postoperative radiotherapy has never been clearly established.

Methods: The experience with a group of 42 patients (16 males, 26 females) with a primary head and neck mucosal melanoma is reported.

Results: Eleven of 19 patients (57.9%) receiving surgery alone developed a regional lymphatic metastasis. For patients receiving postoperative radiotherapy (19 patients), regional metastatic spread occurred in 4 patients (21%). Percentages of local failure were 57.9% (11/19) and 26.3% (5/19) for patients treated with surgery alone and for those treated with surgery and radiotherapy, respectively. Distant metastases occurred in 10 of 19 patients (52.6%) receiving surgery alone and in 9 of 19 patients (47.3%) receiving both therapies.

Conclusions: The present evaluation confirms a poor prognosis for patients with head and neck mucosal melanoma, independent of the treatment modality.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / radiotherapy*
  • Head and Neck Neoplasms / surgery
  • Humans
  • Italy
  • Male
  • Medical Records
  • Melanoma / pathology
  • Melanoma / radiotherapy*
  • Melanoma / surgery
  • Middle Aged
  • Mucous Membrane / pathology
  • Mucous Membrane / radiation effects*
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Netherlands
  • Postoperative Period
  • Prognosis
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome